INR 134.0
(-3.6%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 291.78 Million INR | 92.65% |
2022 | 151.46 Million INR | 14.58% |
2021 | 132.19 Million INR | 73.6% |
2020 | 76.14 Million INR | -30.72% |
2019 | 109.91 Million INR | -1.93% |
2018 | 112.06 Million INR | 25.79% |
2017 | 89.09 Million INR | 4.93% |
2016 | 84.91 Million INR | -10.39% |
2015 | 94.76 Million INR | -1.03% |
2014 | 95.74 Million INR | 34.84% |
2013 | 71 Million INR | 83.34% |
2012 | 38.73 Million INR | 56.68% |
2011 | 24.71 Million INR | 20.66% |
2010 | 20.48 Million INR | 36.07% |
2009 | 15.05 Million INR | -35.48% |
2008 | 23.33 Million INR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 FY | 291.78 Million INR | 92.65% |
2023 Q4 | 291.78 Million INR | 0.0% |
2023 Q3 | - INR | -100.0% |
2023 Q2 | 241.98 Million INR | 0.0% |
2023 Q1 | - INR | -100.0% |
2022 Q1 | - INR | -100.0% |
2022 Q2 | 152.74 Million INR | 0.0% |
2022 Q3 | - INR | -100.0% |
2022 Q4 | 151.46 Million INR | 0.0% |
2022 FY | 151.46 Million INR | 14.58% |
2021 Q1 | - INR | -100.0% |
2021 Q3 | - INR | -100.0% |
2021 Q4 | 132.19 Million INR | 0.0% |
2021 Q2 | 115.99 Million INR | 0.0% |
2021 FY | 132.19 Million INR | 73.6% |
2020 Q4 | 76.14 Million INR | 0.0% |
2020 Q2 | 93.97 Million INR | 0.0% |
2020 FY | 76.14 Million INR | -30.72% |
2019 Q2 | 117.99 Million INR | 0.0% |
2019 FY | 109.91 Million INR | -1.93% |
2019 Q4 | 109.91 Million INR | 0.0% |
2018 Q4 | 112.06 Million INR | 0.0% |
2018 FY | 112.06 Million INR | 25.79% |
2018 Q2 | 99.52 Million INR | 0.0% |
2017 Q2 | 88.03 Million INR | 0.0% |
2017 Q4 | 89.09 Million INR | 0.0% |
2017 FY | 89.09 Million INR | 4.93% |
2016 Q4 | 84.91 Million INR | 0.0% |
2016 FY | 84.91 Million INR | -10.39% |
2016 Q2 | 98.04 Million INR | 0.0% |
2015 Q4 | 94.76 Million INR | 0.0% |
2015 Q2 | 122.94 Million INR | 0.0% |
2015 FY | 94.76 Million INR | -1.03% |
2014 Q2 | 64.14 Million INR | 0.0% |
2014 Q4 | 95.74 Million INR | 0.0% |
2014 FY | 95.74 Million INR | 34.84% |
2013 FY | 71 Million INR | 83.34% |
2013 Q2 | 68.07 Million INR | 0.0% |
2013 Q4 | 71 Million INR | 0.0% |
2012 Q2 | 28.72 Million INR | 0.0% |
2012 FY | 38.73 Million INR | 56.68% |
2012 Q4 | 38.73 Million INR | 0.0% |
2011 FY | 24.71 Million INR | 20.66% |
2011 Q4 | 24.71 Million INR | 0.0% |
2010 FY | 20.48 Million INR | 36.07% |
2009 FY | 15.05 Million INR | -35.48% |
2008 Q4 | 23.33 Million INR | 0.0% |
2008 FY | 23.33 Million INR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Chandra Bhagat Pharma Limited | 727.95 Million INR | 59.917% |
Checkpoint Trends Limited | 4 Million INR | -7181.491% |
Everest Organics Limited | 1.8 Billion INR | 83.869% |
GUJARAT INJECT (KERALA) LTD. | 1.47 Million INR | -19736.098% |
NATURO INDIABULL LIMITED | 537.34 Million INR | 45.698% |
NEXUS SURGICAL AND MEDICARE LI | 12.39 Million INR | -2253.147% |
Rajnish Wellness Limited | 222.75 Million INR | -30.99% |
Vivo Bio Tech Limited | 827.33 Million INR | 64.732% |